Navigation Links
Optogenetic tool elucidated
Date:2/28/2012

Controlling nerve cells with the aid of light: this is made possible by optogenetics. It enables, for example, the investigation of neurobiological processes with unprecedented spatial and temporal precision. The key tool of optogenetics is the light-activated protein channelrhodopsin. Biophysicists from Bochum and Berlin have now succeeded in explaining the switching mechanism through an interdisciplinary approach. The researchers report on their findings in the Journal of Biological Chemistry.

Redistribution of water molecules

Until now, little has been known about the mechanism of the protein - especially about how the channel opens. However, deeper understanding is a prerequisite in order to be able to use the light-controlled protein specifically for neurobiological applications. In a new, multi-disciplinary approach, the Bochum scientists led by Prof. Dr. Klaus Gerwert (Department of Biophysics at the RUB) and their cooperation partners in Berlin have been able to shed light on the switching mechanism. The result: the light-induced change in the charge state of amino acid glutamate 90 (E90) triggers an increased penetration of water molecules, so that the protein can now purposefully conduct ions through the cell membrane.

Three methods combined

Using time-resolved infrared spectroscopy, the RUB biophysicists Jens Kuhne and Dr. Erik Freier have been able to show for the first time that the channel is opened through the deprotonation of the amino acid glutamate 90 (E90). In addition, the electrophysiological experiments of the researchers in Berlin confirm that a mutation of the amino acid leads to a change in the ion permeability of the protein. Instead of using safety goggles and lab coats, the two biophysicists Kirstin Eisenhauer and Dr. Steffen Wolf at the Department of Biophysics used supercomputers to simulate how the protonation change of the glutamate opens the channel and allows water molecules to penetrate.

Internationally preeminent

The work has attained particular distinction right now, because shortly after the Bochum pre-publication on the Internet, Japanese researchers published the three-dimensional structure of a channelrhodopsin online in "Nature". "The structure work impressively confirms our biomolecular simulations and the key role played by the amino acid E90 in the switching of the channel", says Prof. Klaus Gerwert. "We are therefore particularly proud to have been preeminent in this internationally competitive field." In 2010, optogenetics was distinguished by "Nature Methods" as the "Method of the Year". Using this method, researchers have succeeded, for example, in restoring the eyesight of blind mice.


'/>"/>

Contact: Dr. Klaus Gerwert
gerwert@bph.rub.de
49-234-322-4461
Ruhr-University Bochum
Source:Eurekalert

Related biology news :

1. Light workout: Stanford scientists use optogenetics to effectively stimulate muscle movement in mice
2. The leading edge of stress: New genomic, optogenetic and epigenetic findings
3. Connection elucidated between obesity, salt sensitivity and high blood pressure
4. A new signaling pathway of the immune system is elucidated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/14/2016)... 14, 2016  xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/21/2016)... VANCOUVER, British Columbia , June 21, 2016 ... been appointed to the new role of principal ... has been named the director of customer development. ... , NuData,s chief technical officer. The moves reflect ... development teams in response to high customer demand ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... ... December 05, 2016 , ... In anticipation of AxioMed’s exclusive ... production, company President, Jake Lubinski will be traveling to Germany on December 6th. ... Cologne and Karlsruhe to discuss the benefits of a viscoelastic total disc replacement. ...
(Date:12/5/2016)... , Dec. 5, 2016  Eisai Inc. ... open-label two-year study of rufinamide, which were presented ... Epilepsy Society (AES) held from December 2-6 in ... final two-year safety, tolerability and cognitive data showed ... experienced similar safety and tolerability profiles, cognitive development ...
(Date:12/4/2016)... 2016  In five studies being presented today during ... and Exposition in San Diego , ... the delivery of life-saving treatments to patients with a ... to carry therapies directly to the sites in the ... a substantial advantage over traditional, systemic methods. The studies ...
(Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
Breaking Biology Technology: